Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 11:02 AM ET

Biotechnology

Company Overview of Pharmacyclics Inc.

Executive Profile

Eric H. Halvorson

Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
65$243,699

Background

Mr. Eric H. Halvorson has been Of Counsel to the law firm of Stowell, Zeilenga, Ruth, Vaughn & Treiger, LLP since 2010. Mr. Halvorson served as the Chief Executive Officer at The Thomas KinKade Company, Inc. (formerly, Media Arts Group, Inc.) since January 1, 2004 until 2005 and also served as its President since June 23, 2003 to 2005. He served as President of Salem Communications Corp., of Salem Communications Holding, Corp. from July 1, 2007 to September 30, 2008, ...

Corporate Headquarters

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships

Director
2001-N/A
Former Chief Executive Officer, President and Director
2001-Present
Director and Director of Salem Communications Corporation
2002-N/A
Former Director
2003-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2011-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

BS
Bob Jones University
JD
Duke University School of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$243,699
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
$2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
$11.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pharmacyclics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.